HomeInsights52 Week Low Stocks

Marksans Pharma Ltd 52 Week Low

Marksans Pharma Ltd 52 Week Low

stocks purchased

₹ 2.6 Cr

Volume Transacted

(Jan 8, 2025)

stocks purchased

92.8 K

Stocks Traded

(Jan 8, 2025)

Last Updated on: Jan 08, 2025

Image

Marksans Pharma Ltd

NSE: MARKSANS

YEARLOW

₹ 126.05

Last updated on: Jan 07, 2025

Key Highlights

  • The 52 Week Low of Marksans Pharma Ltd is ₹ 126.05 as of 07 Jan 25 .

Company Fundamentals for Marksans Pharma Ltd

No data available

Market Price of Marksans Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Jan 2025283.4
07 Jan 2025289.5
06 Jan 2025285.35
03 Jan 2025297.55
02 Jan 2025298
01 Jan 2025304.7
31 Dec 2024296.7
30 Dec 2024287.35
27 Dec 2024293.6
26 Dec 2024290.15

Asset Value vs Market Value of Marksans Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Marksans Pharma Ltd

No data available

* All values are in crore

Marksans Pharma Ltd News Hub

News

Marksans Pharma receives USFDA approval for Loratadine Tablets

Marksans Pharma announced the final approval of the Company's Abbreviated New Drug Applica...

Read more

22 Nov 2024 12:47

News

Marksans Pharma gains after receiving final nod for Loratadine Tablets from USFDA

The said drugs are indicated for the treatment of allergic rhinitis caused by pollen and u...

Read more

22 Nov 2024 13:23

News

Marksans Pharma gains after Q2 PAT rises 16% YoY to Rs 97 cr

The firm stated that growth was witnessed across all key markets, led by US and followed b...

Read more

12 Nov 2024 13:22

News

Marksans Pharma to declare Quarterly Result

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 12 Novembe...

Read more

23 Oct 2024 17:41

News

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

21 Aug 2024 20:00

News

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...

Read more

20 Aug 2024 14:37

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Marksans Pharma Ltd

Why is it important to track the 52-week low of Marksans Pharma Ltd stocks?

Investors should monitor the 52-week low of Marksans Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Marksans Pharma Ltd stocks hitting a 52-week low?

Factors leading to Marksans Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Marksans Pharma Ltd stocks when they hit a 52-week low?

Buying Marksans Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Marksans Pharma Ltd stocks?

Investors should monitor the 52-week low of Marksans Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Marksans Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Marksans Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Marksans Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Marksans Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Marksans Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions